iSpecimen Inc. Common Stock

ISPCNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
1.18 USD
↘ 0.05 (4.07%)AT CLOSE (03:59 PM EDT)
1.18
↘ 0.01 (0.42%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
1.18
↘ 0.01 (0.42%)
🔴Market: CLOSED

Shares of iSpecimen Inc. Common Stock (ISPC) are trading at $1.18. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Sep 30, 2026.

Open?$1.20
High?$1.24
Low?$1.18
Prev. Close?$1.23
Volume?62.7K
Avg. Volume?1.3M
VWAP?$1.21
Rel. Volume?0.05x
Bid / Ask
Bid?$1.15 × 1.1K
Ask?$1.18 × 100
Spread?$0.03
Midpoint?$1.17
Valuation & Ratios
Market Cap?3.0M
Shares Out?2.5M
Float?1.5M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?1.71
EPS?-$4.53
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
Themes
Biotech - Drug Development›Clinical-Stage Platforms
Employees
7
Market Cap
3.1M
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Website
www.ispecimen.com
Listed
2021-06-17
Address
8 CABOT ROAD
WOBURN, MA 08101
Phone: 781-301-6700
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
40
Short Sent.?
63
Piotroski F-Score?2/9Weak
Altman Z-Score?-46.78Distress
Confidence?53%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?14.50%High
Short Interest?220.7K
Days to Cover?1.0
Free Float1.5M
Avg Daily Volume2.2M
Settlement Date2026-09-15
Financial Health
Current Ratio?0.82Weak
Quick Ratio?0.82Weak
Cash Ratio?0.81Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
82
1.71CHEAP▾
P/S?
Peers
100
S&P
20
6.37FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.2CHEAP▾
EV/Sales?
S&P
97
-3.09CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-657.7%WEAK▾
ROA?
S&P
3
-154.5%WEAK▾
Cash Flow & Enterprise
FCF?$-7004000
Enterprise Value?$-1442428
Fundamentals ratios updated end of day
MarketsMoversWatchlist